CC
OPRX icon

Corton Capital’s OptimizeRx OPRX Stock Holding History

Corton Capital’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,194
Closed -$138K – 350
2025
Q2 		$138K Buy
+10,194
New +$112K 0.16% 289
2025
Q1 		– Sell
-22,610
Closed -$110K – 341
2024
Q4 		$110K Buy
+22,610
New +$126K 0.06% 341
2024
Q1 		– Sell
-10,663
Closed -$153K – 623
2023
Q4 		$153K Buy
+10,663
New +$102K 0.05% 513

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Corton Capital's OPRX Position: Q3 2025 in Review

Corton Capital sold out of OptimizeRx (OPRX) in Q3 2025, closing a stake of 10,194 shares — an estimated $138K sold.

Corton Capital first reported a position in OPRX in Q4 2023 and held it in 3 quarters. The position peaked at $153K in Q4 2023. 125 funds tracked by Wall St. Rank hold OPRX as of Q3 2025.

  • Corton Capital reported no remaining OptimizeRx position as of Q3 2025 after selling out during the quarter.
  • Corton Capital sold 10,194 OptimizeRx shares in Q3 2025, an estimated $138K.
  • Corton Capital first reported a position in OptimizeRx in Q4 2023 and held it in 3 quarters.
  • Corton Capital's OptimizeRx position peaked at $153K in Q4 2023.
  • 125 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2025.

Based on Corton Capital's 13F filing for Q3 2025, filed 14 Nov 2025.